Why have teenagers been left out of psychedelic therapy research, and what are the ethical considerations for including them in the future? Synopsis This article explores a significant gap in the current psychedelic research landscape: the exclusion of adolescents. While psychedelic-assisted therapies are showing promise...
Are low-dose ketamine infusions a safe and effective treatment for chronic pain? Synopsis A large real-world study has demonstrated that low-dose ketamine infusions are both safe and significantly effective for patients suffering from chronic pain. This article will delve into the findings of this study,...
How safe is psilocybin when used in clinical trials, and what are the risks involved? Synopsis Recent research indicates that serious adverse events in psilocybin clinical trials are extremely rare. This article examines the safety profile of psilocybin as a therapeutic agent, discussing the potential...
Does psilocybin offer a new hope for individuals suffering from obsessive-compulsive disorder (OCD)? Synopsis A review of 13 studies has shown that psilocybin, the psychoactive compound in magic mushrooms, consistently reduces symptoms of obsessive-compulsive disorder (OCD). This article will explore the evidence behind psilocybin's efficacy...